Evaluating Benefits of Hearing Aid Microphone Directionality Technologies
NCT ID: NCT04953390
Last Updated: 2022-11-09
Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
19 participants
INTERVENTIONAL
2021-05-03
2021-07-02
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Real World Perspectives on Advancements in Hearing Aid Technology
NCT05468918
A Comparison of Hearing Aid Noise Programs on Speech Intelligibility
NCT06957730
Hearing Aid Performance Study for Different Spatial Configurations
NCT05284903
In Field Performance of a Hearing Aid Transducer
NCT04787055
Evaluation of Hearing Aid Benefit
NCT05198713
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Experimental
All study participants wearing study devices and evaluating three different microphone settings in simulated noise environments in lab, and using study devices during home trial period.
Phonak Audeo hearing aid
Commercially available hearing aid with three different microphone settings: DIR1, DIR2, and DIR3
Phonak hearing aid with multiple directionality settings, adjustable via a mobile app
Commercially available hearing aid with multiple directionality settings which will be adjustable by user via a mobile app during a home trial period.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Phonak Audeo hearing aid
Commercially available hearing aid with three different microphone settings: DIR1, DIR2, and DIR3
Phonak hearing aid with multiple directionality settings, adjustable via a mobile app
Commercially available hearing aid with multiple directionality settings which will be adjustable by user via a mobile app during a home trial period.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* experienced hearing aid users
* moderate to moderate severe sensorineural symmetrical hearing loss defined as a difference of less than 10 dB between ears
* must be able to use app and smart phone
Exclusion Criteria
* unable or unwilling to use app and smart phone
18 Years
90 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Sonova AG
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Kevin Seitz-Paquette, AuD
Role: PRINCIPAL_INVESTIGATOR
Sonova AG
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Sonova
Aurora, Illinois, United States
Countries
Review the countries where the study has at least one active or historical site.
Provided Documents
Download supplemental materials such as informed consent forms, study protocols, or participant manuals.
Document Type: Study Protocol and Statistical Analysis Plan
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
SRF-369
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.